PF-Atlas › Clinical Trials › NCT02277626

Electro Flo 5000 and Vest Therapy

Electro Flo 5000 · Phase 4

Registry ID
NCT02277626
Phase
Phase 4
Status
Completed
Drug / intervention
Electro Flo 5000
Sponsor
Stanford University
Start
2012-04

About this trial

Electro Flo 5000 is evaluated in NCT02277626, a Phase 4 idiopathic pulmonary fibrosis study sponsored by Stanford University. Current status: Completed.

View NCT02277626 on ClinicalTrials.gov →

Explore related

All Electro Flo 5000 trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT02277626 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.